CombiGene’s Chairman of the Board comments on the future

CombiGene is preparing for clinical studies together with partner Spark Therapeutics. BioStock contacted the company’s Chairman of the Board, Bert Junno, to learn more about the company and to find out what will be discussed at the upcoming Annual General Meeting on May 19. Among other things, we get to know more about the details of the proposed incentive programme.